Technology News and Research

RSS

Study shows flash glucose monitors help youth with type1 diabetes

A world-first Otago study has revealed flash glucose monitors help youth with type 1 diabetes better monitor their blood sugar levels, however it does not improve glucose control.

8 Oct 2020

Researchers track down two new relatives of rubella virus

At night in a Ugandan forest, a team of American and African scientists take oral swabs from insect-eating cyclops leaf-nosed bats.

8 Oct 2020

DARPA selects Purdue-affiliated company to develop continuous manufacturing technology

The COVID-19 pandemic has created supply chain gaps in critical drug products, especially those needed for the most critical patients in intensive care units across the country.

7 Oct 2020

Rapid, low-cost test for potential universal COVID-19 monitoring

An international team of researchers has presented a convenient, low-cost serology test to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could potentially be made available universally.

7 Oct 2020

Robotic exoskeleton improves lives of people with limited or no hand mobility

The Engineering Design and Technological Development Group (DIDET), from the University of Alicante ArtefactosLAB, has once again taken a step forward in terms of social innovation with the design of a new handheld robotic exoskeleton.

7 Oct 2020

uOttawa partners with The Royal to provide new telemedicine service for students

The University is proud to announce a new partnership with The Royal that will allow students access to an additional service: A Psychiatric Virtual Consultation Clinic.

7 Oct 2020

New efficacies of Ganoderma lucidum as anti-inflammatory agent for the skin

Ganoderma lucidum, known as Yeongji mushroom in Korea, is called a modern-day elixir plant and has long been used medicinally in China, Japan and Korea.

7 Oct 2020

Biodegradable microneedle patch for local therapeutic gene delivery

There is great potential in gene therapy for treating certain types of cancer and genetic defects, immunological diseases, wounds and infections. The therapies work by delivering genes into the patients' cells, which then produce therapeutic proteins to treat the affliction.

7 Oct 2020

Theoretical model explains biological phenomena that keep bacteria in shape

Fat bacteria? Skinny bacteria? From our perspective on high, they all seem to be about the same size. In fact, they are.Precisely why has been an open question, according to Rice University chemist Anatoly Kolomeisky, who now has a theory.

7 Oct 2020

Sofosbuvir combined with other antivirals is more effective against COVID-19, shows study

Columbia Engineering researchers report that Sofosbuvir-terminated RNA is more resistant to the proofreader of SARS-CoV-2, the virus that causes COVID-19, than Remdesivir-terminated RNA.

7 Oct 2020

A global review of COVID-19 impact on cancer treatment and research

The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.

7 Oct 2020

DFG establishes new research units

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is setting up six new Research Units and a new Clinical Research Unit. The DFG Joint Committee decided this on the recommendation of the Senate.

7 Oct 2020

Researchers have discovered a safe, non-invasive way to manage blood sugar

Researchers from the University of Iowa may have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes two major hallmarks of type 2 diabetes, according to new findings published Oct. 6 in Cell Metabolism.

7 Oct 2020

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

In a recent preprint paper published on the bioRxiv server, researchers from the Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, IN, discuss their efforts to assess the 4 SARS-CoV-2 structural proteins for their ability to produce VLPs from human cells to create a competent system for BSL-2 studies of SARS-CoV-2.

6 Oct 2020

UChicago genomics researcher wins NIH Director's New Innovator Award

Oni Basu, PhD, an assistant professor of genetic medicine at the University of Chicago, has received the prestigious National Institutes of Health Director's New Innovator Award.

6 Oct 2020

A new technology to measure lens stiffness associated with presbyopia

A University of Houston biomedical researcher is developing new technology that will measure the stiffness of the lens in the eye, which is likely associated with presbyopia, or farsightedness, the inevitable and age-related loss of the ability to focus on nearby objects.

6 Oct 2020

Optimized low‐dose drug combinations to effectively treat colorectal cancer

Chemotherapy-based cancer treatment has distressing side effects for patients and increases the risk of developing resistance to the treatment.

6 Oct 2020

Tuned lighting helps improve sleep in nursing home residents, study finds

Nursing home residents tend to fall asleep at all hours of the day, and during the night, their sleep may be interrupted by periods of wakefulness.

6 Oct 2020

UM associate professor wins multiple awards for ear, skin science

University of Montana scientist Monica Serban is on a research roll. In recent months the UM associate professor and her team have earned three awards totaling $3.9 million in funding to study preventing hearing loss among U.S. troops, combating ear infections and creating a synthetic skin product.

6 Oct 2020

ACGT awards $500,000 grant to advance strategies for treating solid tumors

With a $500,000 Research Grant from Alliance for Cancer Gene Therapy, Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member of Yale Cancer Center, will advance a versatile and highly scalable strategy he's been developing and calling MAEGI -- Multiplexed Activation of Endogenous Genes as an Immunotherapy.

6 Oct 2020